196 related articles for article (PubMed ID: 28885545)
1. TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling.
Kawabata H; Azuma K; Ikeda K; Sugitani I; Kinowaki K; Fujii T; Osaki A; Saeki T; Horie-Inoue K; Inoue S
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885545
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of TRIM44 mediates the NF-κB pathway to promote the progression of ovarian cancer.
Yu Y; Li S; Sun J; Wang Y; Xie L; Guo Y; Li J; Han F
Genes Genomics; 2024 Jun; 46(6):689-699. PubMed ID: 38691326
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of specific NF-κB activity contributes to the tumor suppressor function of 14-3-3σ in breast cancer.
Inglés-Esteve J; Morales M; Dalmases A; Garcia-Carbonell R; Jené-Sanz A; López-Bigas N; Iglesias M; Ruiz-Herguido C; Rovira A; Rojo F; Albanell J; Gomis RR; Bigas A; Espinosa L
PLoS One; 2012; 7(5):e38347. PubMed ID: 22675457
[TBL] [Abstract][Full Text] [Related]
4. Daintain/AIF-1 promotes breast cancer proliferation via activation of the NF-kappaB/cyclin D1 pathway and facilitates tumor growth.
Liu S; Tan WY; Chen QR; Chen XP; Fu K; Zhao YY; Chen ZW
Cancer Sci; 2008 May; 99(5):952-7. PubMed ID: 18341653
[TBL] [Abstract][Full Text] [Related]
5. CITED2 Modulates Breast Cancer Metastatic Ability through Effects on IKKα.
Jayaraman S; Doucet M; Lau WM; Kominsky SL
Mol Cancer Res; 2016 Aug; 14(8):730-9. PubMed ID: 27216153
[TBL] [Abstract][Full Text] [Related]
6. The endonuclease FEN1 mediates activation of STAT3 and facilitates proliferation and metastasis in breast cancer.
Wu M; Huang X; Wu B; Zhu M; Zhu Y; Yu L; Lan T; Liu J
Mol Biol Rep; 2024 Apr; 51(1):553. PubMed ID: 38642158
[TBL] [Abstract][Full Text] [Related]
7. NF-κB affects proliferation and invasiveness of breast cancer cells by regulating CD44 expression.
Smith SM; Lyu YL; Cai L
PLoS One; 2014; 9(9):e106966. PubMed ID: 25184276
[TBL] [Abstract][Full Text] [Related]
8. NKAIN1, as an oncogene, promotes the proliferation and metastasis of breast cancer, affecting its prognosis.
Wang X; Yang F; Sun Z; Zhao G; Pu Q; Geng C; Dong K; Zhang X; Liu Z; Song H
Mol Carcinog; 2024 Jul; 63(7):1392-1405. PubMed ID: 38651944
[TBL] [Abstract][Full Text] [Related]
9. Negative role of trihydrophobin 1 in breast cancer growth and migration.
Zou W; Yang Y; Wu Y; Sun L; Chi Y; Wu W; Yun X; Xie J; Gu J
Cancer Sci; 2010 Oct; 101(10):2156-62. PubMed ID: 20735431
[TBL] [Abstract][Full Text] [Related]
10. DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms.
Lemler DJ; Lynch ML; Tesfay L; Deng Z; Paul BT; Wang X; Hegde P; Manz DH; Torti SV; Torti FM
Breast Cancer Res; 2017 Mar; 19(1):25. PubMed ID: 28270217
[TBL] [Abstract][Full Text] [Related]
11. TRIM39 negatively regulates the NFκB-mediated signaling pathway through stabilization of Cactin.
Suzuki M; Watanabe M; Nakamaru Y; Takagi D; Takahashi H; Fukuda S; Hatakeyama S
Cell Mol Life Sci; 2016 Mar; 73(5):1085-101. PubMed ID: 26363554
[TBL] [Abstract][Full Text] [Related]
12. Protein interacting with C alpha kinase 1 (PICK1) is involved in promoting tumor growth and correlates with poor prognosis of human breast cancer.
Zhang B; Cao W; Zhang F; Zhang L; Niu R; Niu Y; Fu L; Hao X; Cao X
Cancer Sci; 2010 Jun; 101(6):1536-42. PubMed ID: 20384629
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of Nuclear Factor Kappa B (p65) among Breast Cancer Patients in Cape Coast Teaching Hospital.
Barnes P; Mensah A; Derkyi-Kwarteng L; Adankwa E; Agbo E; Yahaya ES; Amoani B; Adjei G; Ka-Chungu SMA; Akakpo PK; Halm-Lai F; Dankwa K; Amoako-Sakyi D; Nuvor SV; Obiri-Yeboah D; Saahene RO
Med Princ Pract; 2024 May; ():1-11. PubMed ID: 38723618
[TBL] [Abstract][Full Text] [Related]
14. A New Herbal Formula, KSG-002, Suppresses Breast Cancer Growth and Metastasis by Targeting NF- κ B-Dependent TNF α Production in Macrophages.
Woo SM; Choi YK; Cho SG; Park S; Ko SG
Evid Based Complement Alternat Med; 2013; 2013():728258. PubMed ID: 23818931
[TBL] [Abstract][Full Text] [Related]
15. TRIM44 promotes human esophageal cancer progression via the AKT/mTOR pathway.
Xiong D; Jin C; Ye X; Qiu B; Jianjun X; Zhu S; Xiang L; Wu H; Yongbing W
Cancer Sci; 2018 Oct; 109(10):3080-3092. PubMed ID: 30098109
[TBL] [Abstract][Full Text] [Related]
16. TRIM44 promotes cell proliferation and migration by inhibiting FRK in renal cell carcinoma.
Yamada Y; Kimura N; Takayama KI; Sato Y; Suzuki T; Azuma K; Fujimura T; Ikeda K; Kume H; Inoue S
Cancer Sci; 2020 Mar; 111(3):881-890. PubMed ID: 31883420
[TBL] [Abstract][Full Text] [Related]
17. TRIM59 promotes breast cancer motility by suppressing p62-selective autophagic degradation of PDCD10.
Tan P; Ye Y; He L; Xie J; Jing J; Ma G; Pan H; Han L; Han W; Zhou Y
PLoS Biol; 2018 Nov; 16(11):e3000051. PubMed ID: 30408026
[TBL] [Abstract][Full Text] [Related]
18. TRIM67 Activates p53 to Suppress Colorectal Cancer Initiation and Progression.
Wang S; Zhang Y; Huang J; Wong CC; Zhai J; Li C; Wei G; Zhao L; Wang G; Wei H; Zhao Z; Yu J
Cancer Res; 2019 Aug; 79(16):4086-4098. PubMed ID: 31239268
[TBL] [Abstract][Full Text] [Related]
19. TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway.
Liu Y; Tao S; Liao L; Li Y; Li H; Li Z; Lin L; Wan X; Yang X; Chen L
Nat Commun; 2020 Jan; 11(1):348. PubMed ID: 31953436
[TBL] [Abstract][Full Text] [Related]
20. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex.
Guo P; Ma X; Zhao W; Huai W; Li T; Qiu Y; Zhang Y; Han L
Oncogene; 2018 Jan; 37(4):478-488. PubMed ID: 28967907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
